Abstract
Thirty-nine isolates of Cryptococcus neoformans, nineteen serotype AD and twenty serotype BC, were assayed for susceptibility to eight antifungal agents using an in vitro agar dilution assay. Media employed were Kimmig agar and yeast nitrogen base supplemented with 10% glucose. The antifungal agents used were ketoconazole, amphotericin B, 5-fluorocytosine, nystatin, miconazole, BAY N 7133, ICI 153,066, and itraconazole. No clinically significant differences in in vitro minimum inhibitory concentrations were detected between serotypes AD and BC against any of the compounds tested. An adverse medium effect was observed in two of the assays, but the outcome of the AD/BC comparison was not affected. This is the first report in which the in vitro antifungal susceptibilities of Cryptococcus neoformans serotypes are analyzed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Fromtling RA, Shadomy S, Shadomy HJ, Dismukes WE: Serotype B/C Cryptococcus neoformans isolated from patients in nonendemic areas. J Clin Microbiol 16:408–410, 1982.
Henderson DK, Edwards Jr JE, Dismukes WE, Bennett JE: Meningitis produced by different serotypes of Cryptococcus neoformans. (Abstract). Abstr Ann Meet Amer Soc Microbiol (Dallas, TX) Abstr F11, 1981.
Jong SC, Bulmer GS, Ruiz A: Serologic grouping and sexual compatibility of airborne Cryptococcus neoformans. Mycopathologia 79:185–188, 1982.
Kwon-Chung KJ, Bennett JE: Epidemiologic differences between the two varieties of Cryptococcus neoformans. Amer J Epidemiol 120:123–130, 1984.
Kwon-Chung KJ, Bennett JE: High prevalence of Cryptococcus neoformans var. gattii in tropical and subtropical regions. Zbl Bakt Hyg A 257:213–218, 1984.
Kwon-Chung KJ, Bennett JE, Rhodes JC: Taxonomic studies on Filobasidiella species and their anamorphs. Antonie van Leeuwenhoek 48:25–38, 1982.
Kwon-Chung KJ, Bennet JE, Theodore TS: Cryptococcus bacillisporus sp. nov. serotype B-C of Cryptococcus neoformans. Int J Syst Bacteriol 28:616–620, 1978.
Kwon-Chung KJ, Polacheck I, Bennett JE: Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotype A and D) and Cryptococcus neoformans var. gattii (serotype B and C). J Clin Microbiol 15:535–537, 1982.
Lehmann PF, Morgan RJ, Freimer EH: Infection with Cryptococcus neoformans var. gattii leading to a pulmonary cryptococcoma and meningitis. J Infec 9:301–306, 1984.
Mishra SK, Staib S, Folkens U, Fromtling RA: Serotypes of Cryptococcus neoformans strains isolated in Germany. J Clin Microbiol 14:106–107, 1981.
Rippon JW: Medical mycology. The pathogenic fungi and the pathogenic actinomycetes, 2nd edition. WB Saunders Co., Philadelphia, 1982, p 532.
Shadomy S, Espinel-Ingroff A, Cartwright RY: Laboratory studies with antifungal agents: susceptibility tests and bioassays. In: EH Lennette, A Balows, WJ Hausler Jr, and HJ Shadomy (eds) Manual of clinical microbiology, 4th edition. Amer Soc Microbiol, Washington, DC, 1985, pp 991–999.
Wilson DE, Bennett JE, Bailey JW: Serologic grouping of Cryptococcus neoformans. Proc Soc Exp Biol Med 127:820–823, 1968.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fromtling, R.A., Abruzzo, G.K. & Bulmer, G.S. Cryptococcus neoformans: Comparisons of in vitro antifungal susceptibilities of serotypes AD and BC. Mycopathologia 94, 27–30 (1986). https://doi.org/10.1007/BF00437258
Issue Date:
DOI: https://doi.org/10.1007/BF00437258